phenylethyl alcohol has been researched along with Depression, Involutional in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, S; D'Souza, DN; Dellva, MA; Goldberger, C; Marangell, LB; Russell, JM | 1 |
| Atkinson, S; Ball, SG; Bangs, M; Dubé, S; Goldberger, C; Sparks, J | 1 |
| Ahl, J; Dellva, MA; Goldberger, C; Greenbaum, M; Oakes, TM; Perahia, DG; Poppe, C; Waterman, K | 1 |
| Fava, M; Goldberger, C; Gorwood, P; Liu, P; Marangell, LB; Nelson, C; Stauffer, VL | 1 |
| D'Souza, DN; Dellva, MA; Essink, B; Goldberger, C; Pangallo, B; Russell, J | 1 |
| Aldenhoff, JB; Ferstl, R; Göder, R; Pause, BM; Raack, N; Sojka, B | 1 |
5 trial(s) available for phenylethyl alcohol and Depression, Involutional
| Article | Year |
|---|---|
A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
Topics: Adult; Antidepressive Agents; Biomarkers; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Morpholines; Phenylethyl Alcohol; Selective Serotonin Reuptake Inhibitors; Sex Factors; Sexual Behavior; Suicidal Ideation; Surveys and Questionnaires; Treatment Outcome | 2014 |
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
Topics: Adjuvants, Pharmaceutic; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2015 |
Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2015 |
A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2011 |
Convergent and divergent effects of odors and emotions in depression.
Topics: Adult; Aldehydes; Color Perception; Depressive Disorder, Major; Electroencephalography; Emotions; Evoked Potentials; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Odorants; Phenylethyl Alcohol; Smell | 2003 |
1 other study(ies) available for phenylethyl alcohol and Depression, Involutional
| Article | Year |
|---|---|
Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder?
Topics: Adrenergic Uptake Inhibitors; Adult; Clinical Trials as Topic; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Morpholines; Norepinephrine; Phenylethyl Alcohol; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors | 2017 |